Checkpoint Inhibitors for Lung Cancer Linked to Pulmonary Embolism
Med Page Today
OCTOBER 8, 2024
(MedPage Today) -- BOSTON -- Patients with metastatic lung cancer who were treated with immune checkpoint inhibitors (ICIs) had higher odds of developing a pulmonary embolism, according to a retrospective cohort study. Among propensity-matched.
Let's personalize your content